UniSa - IRIS Institutional Research Information System

SABBATINO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.942
EU - Europa 1.367
AS - Asia 1.098
SA - Sud America 194
AF - Africa 21
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.631
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.917
SG - Singapore 474
IT - Italia 367
RU - Federazione Russa 281
CN - Cina 229
DE - Germania 224
BR - Brasile 186
IE - Irlanda 98
TR - Turchia 97
FI - Finlandia 96
VN - Vietnam 91
SE - Svezia 66
UA - Ucraina 64
HK - Hong Kong 61
KR - Corea 55
AT - Austria 49
IN - India 39
NL - Olanda 28
CZ - Repubblica Ceca 24
GB - Regno Unito 23
FR - Francia 18
CA - Canada 15
PL - Polonia 12
NP - Nepal 8
JP - Giappone 6
UZ - Uzbekistan 6
MX - Messico 5
ZA - Sudafrica 5
ES - Italia 4
ID - Indonesia 4
MA - Marocco 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
TH - Thailandia 4
AL - Albania 3
AU - Australia 3
BD - Bangladesh 3
DZ - Algeria 3
IQ - Iraq 3
IR - Iran 3
KE - Kenya 3
TN - Tunisia 3
AR - Argentina 2
EG - Egitto 2
GR - Grecia 2
KG - Kirghizistan 2
LT - Lituania 2
MY - Malesia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
EC - Ecuador 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KI - Kiribati 1
MM - Myanmar 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.631
Salva come PNG Salva come JPEG
Città #
Ann Arbor 377
Chandler 304
Princeton 274
Munich 164
Singapore 153
Dublin 94
Naples 92
Dong Ket 91
Izmir 91
Jacksonville 88
Ashburn 78
Moscow 72
Wilmington 69
Beijing 65
Hong Kong 61
Andover 56
Pellezzano 52
Houston 48
Helsinki 42
Nuremberg 42
Nanjing 32
Vienna 32
Salerno 31
Turku 30
Woodbridge 30
Boardman 27
Los Angeles 27
Brno 23
Fairfield 19
The Dalles 19
Pune 17
Changsha 16
Dallas 16
Nanchang 16
Norwalk 14
Sarno 12
Warsaw 12
Fisciano 11
Lappeenranta 11
Paris 11
Milan 10
San Francisco 10
São Paulo 10
New York 9
Amsterdam 8
Columbus 8
Jiaxing 8
San Diego 8
Seattle 8
Shanghai 8
Belo Horizonte 7
Brooklyn 7
Domicella 7
Kathmandu 7
Orange 7
Santa Clara 7
Shenyang 7
Cambridge 6
Hebei 6
Jyväskylä 6
Rio de Janeiro 6
Washington 6
Council Bluffs 5
Redwood City 5
Toronto 5
Zhengzhou 5
Atlanta 4
Brasília 4
Cellole 4
Chennai 4
Chiang Mai 4
Dearborn 4
Jakarta 4
London 4
Mercato San Severino 4
Mumbai 4
San Gennaro Vesuviano 4
Shijiazhuang 4
Stella Cilento 4
Tashkent 4
Tianjin 4
Auckland 3
Bologna 3
Boston 3
Carbonara di Nola 3
Charlotte 3
Chicago 3
Delhi 3
Florence 3
Guarulhos 3
Jinan 3
Juiz de Fora 3
Karachi 3
Manassas 3
Manchester 3
Porto Alegre 3
Prineville 3
Shenzhen 3
Sousse 3
St Petersburg 3
Totale 3.022
Salva come PNG Salva come JPEG
Nome #
Abstract 3132: Single nucleotide polymorphisms (SNPs) in PD-L1 as predictive biomarkers for checkpoint inhibitor based-immunotherapy in caucasian patients with advanced NSCLC 227
Antitumor activity of BRAF inhibitor and IFN×alpha; Combination in BRAF-mutant melanoma 111
Cell growth-inhibition and cell cycle perturbations induced by a new synthetic iminoquinone, 5H-pyridophenoxazin-5-one, in human breast carcinoma cell lines. 105
Inhibition of NF-kB activity potentiates ionizing radiation and cisplatin induced cell killing of anaplastic thyroid carcinoma cells AACR Meeting Abstracts, Apr 2006; 2006: 1038. 104
The farnesyltransferase inhibitor R115777 (Zanestra) synergizes with ionizing radiation in inducing cell cycle perturbation and growth inhibition of human epidermoid head and neck cancer cells. 96
Abstract 4017: Anti-tumor activity of a BRAF inhibitor and IFNα combination in BRAF mutant melanoma 90
Counteracting resistance to treatments in solid tumors. 86
Abstracts of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2011. September 10-14, 2011. Munich, Germany 79
Abstract 3703: PDGFRα up-regulation mediated by Sonic Hedgehog Pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation 76
Abstracts of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2010. October 2-6, 2010. Valencia, Spain 73
Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase i inhibitor or radiation 72
Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC 72
PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation. 71
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors 70
Abstract 3639: Combinatorial therapy for triple negative breast cancer 69
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer 67
Molecules and mechanisms to overcome oxidative stress inducing cardiovascular disease in cancer patients 65
A genotyping/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: Clinical cases and systematic review of the literature 64
Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells 63
Abstract 4741: Inhibition of TNBC cell growth by CSPG4-specific mAb 225.28 with a Sonic Hedgehog pathway inhibitor 62
597 IMPACT OF CONTRAST-ENHANCED ULTRASONOGRAPHY ON DIAGNOSTIC WORK-UP OF FOCAL LIVER ANOMALIES: EXPERIENCE IN A SINGLE HEPATOLOGY UNIT 62
The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology 61
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma 60
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 58
Blocking the formation of radiation-induced breast cancer stem cells 57
Variability in immune infiltrates and HLA expression in cholangiocarcinoma 54
"Idealized" vs. "true" learning curves: The case of laparoscopic liver resection 54
Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology 54
Multidisciplinary approach to patient with malignant melanoma 52
Epigenetic control of gene expression: Potential implications for cancer treatment 50
Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma 48
P.1.279: ADVANCED HCC ABLATION AFTER DOWSTAGING WITH SORAFENIB 48
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 48
Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients 48
Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers 48
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells 47
Ipilimumab in the treatment of metastatic melanoma: Management of adverse events 47
PD-L1 Dysregulation in COVID-19 Patients 47
Emerging BRAF inhibitors for melanoma 47
Identification of Drug Interaction Adverse Events in Patients with COVID-19: A Systematic Review 47
Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review 46
Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma 45
Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumors 44
Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature 44
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer 43
Ki67 in Gleason Pattern 3 as a Marker of the Presence of Higher-Grade Prostate Cancer 43
Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches 41
Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives 41
rs822336 as a predictive biomarker for anti-PD-1/PD-L1 immunotherapy in advanced NSCLC: Unraveling molecular mechanisms 40
Immune Checkpoint Inhibitors in Melanoma and HIV Infection 40
PHH3 immunostaining: a novel prognostic biomarker in pancreatic neuroendocrine tumors 40
P.1.159: REPEATED LOCO-REGIONAL TREATMENTS: HIGH SURVIVAL RATES IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA HIGHLY COMPLIANT TO SCHEDULED FOLLOW-UP 40
Diagnosis of Langerhans cell histiocytosis on cytological examination of cerebrospinal fluid: Report of the first case 39
Can the "right" EGFR-specific mAb dramatically improve EGFR-targeted therapy? 39
Genetic evolution of T-cell resistance in the course of melanoma progression 39
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC 38
Harnessing host innate immunity may combat acquired resistance to BRAFi 38
Effect of tocilizumab in reducing the mortality rate in covid-19 patients: A systematic review with meta-analysis 38
XXV Conferenza Nazionale di Citometria: CELL GROWTH INHIBITION AND CELL CYCLE PERTURBATIONS INDUCED BY A NEW SYNTHETIC IMINOQUINONE, 5H-PYRIDOPHENOXAZIN-5-ONE, IN HUMAN BREAST CARCINOMA CELL LINES 37
A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation 37
Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors 36
21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy 34
XXV Conferenza Nazionale di Citometria: INHIBITION OF POLY (ADP-RIBOSE) POLYMERASE SYNERGIZES WITH THE DNA-TOPOISOMERASE-1-INHIBITOR, TOPOTECAN, AND RADIATION IN HUMAN GLIOBLASTOMA CELL LINE 34
Testing egfr with idylla on cytological specimens of lung cancer: A review 34
Case Report: BAP1 Mutation and RAD21 Amplification as Predictive Biomarkers to PARP Inhibitor in Metastatic Intrahepatic Cholangiocarcinoma 32
The ratio of grzb+ − foxp3+ over cd3+ t cells as a potential predictor of response to nivolumab in patients with metastatic melanoma 32
KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies 31
Different Prognostic Role of Soluble PD-L1 in the Course of Severe and Non-Severe COVID-19 31
An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy 31
Proceedings of the XXII National Conference of the Italian Society of Cytometry GIC, October 4–8, 2005, San Bendetto del Tronto (AP), Italy 31
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram 31
Natural Health Products for Anti-Cancer Treatment: Evidence and Controversy 30
Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapy 30
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum 30
Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review 29
Tissue micro arrays for immunohistochemical detection of inflammatory infiltrates in renal cell carcinoma 29
P.1.112: IMPACT OF CONTRAST-ENHANCED ULTRASONOGRAPHY ON DIAGNOSTIC WORK-UP OF FOCAL LIVER ANOMALIES: EXPERIENCE IN A SINGLE HEPATOLOGY UNIT 29
Immune checkpoint inhibitors for the treatment of melanoma 29
Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors 29
Concomitant Administration of Capecitabine and Folate Supplements: Need to Encourage Medication Reconciliation 28
PD-L1 and HLA class i antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma 28
Melanoma initiating cells: where do we stand? 26
Monoclonal antibody-based immunotherapy of ovarian cancer: Targeting ovarian cancer cells with the B7-H3-specific mAb 376.96 26
Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy, Cancer Initiating Cells and Disease Recurrence 26
Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cells 26
Novel combinatorial therapy for pancreatic adenocarcinoma 26
Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy 25
Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study 24
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors 23
The Current and Future Impact of Lymph Node Fine-Needle Aspiration Cytology on Patient Care 22
Cytopathological differential diagnosis of malignant tumor cells in the cerebrospinal fluid: A retrospective analysis 21
Clinical and genetic drivers of oligo-metastatic disease in colon cancer 21
Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors 21
BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancer 20
High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease 19
Advancing the integration of biosignal-based automated pain assessment methods into a comprehensive model for addressing cancer pain 19
Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study 18
Back to the Bench: Unveiling the Tissue Context is Crucial to Enhance the Efficacy of Agnostic Therapies in Oncology 17
Combined fine needle aspiration cytology and core needle biopsy in the same setting: A two-years' experience 16
KRAS mutations in advanced non-small cell lung cancer: From biology to novel therapeutic strategies 16
Totale 4.631
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.641
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021226 10 7 13 7 10 19 21 3 7 1 20 108
2021/2022462 7 0 2 1 22 5 2 19 79 50 66 209
2022/2023752 77 80 68 128 55 144 1 48 98 1 42 10
2023/2024555 41 42 37 37 37 59 44 29 35 37 29 128
2024/20251.792 44 17 28 66 90 195 322 138 335 141 198 218
2025/202624 24 0 0 0 0 0 0 0 0 0 0 0
Totale 4.897